Eradication of helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance

Journal of Infectious Diseases

Volumn 208, Issue 7, 2013, Pages 1123-1130

  Lee, Hyun Jeong ^a   Kim, Jin Il ^a   Cheung, Dae Young ^a   Kim, Tae Ho ^a   Jun, Eun Jung ^a   Oh, Jung Hwan ^a   Chung, Woo Chul ^a   Kim, Byung Wook ^a   Kim, Sung Soo ^a   Park, Soo Heon ^a   Kim, Jae Kwang ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Clarithromycin; drug resistance; Helicobacter pylori; point mutation

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; RABEPRAZOLE; RNA 23S; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BITTER TASTE; BLOATING; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HAIR LOSS; HALITOSIS; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LOOSE FECES; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTICENTER STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NAUSEA; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RNA GENE; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST; VOMITING; WEAKNESS; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

CLARITHROMYCIN; DRUG RESISTANCE; HELICOBACTER PYLORI; POINT MUTATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTON PUMP INHIBITORS; RNA, RIBOSOMAL, 23S; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887274956     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit287     Document Type: Article

References (25)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347:1175-86
2. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24:1587-600
3. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15:1-20
4. Kim N, Kim JJ, Choe YH, et al. Diagnosis and treatment guideline for Helicobacter pylori infection in Korea. Korean J Gastroenterol 2009; 54:269-78
5. Kim BW, Choi MG, Choi H, et al. Pooled analysis of antibiotic therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol 1999; 34:42-9
6. Cho DK, Park SY, Kee WJ, et al. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J Gastroenterol 2010; 55:368-75
7. Choi YS, Cheon JH, Lee JY, et al. The trend of eradication rates of firstline triple therapy for Helicobacter pylori infection: Single center experience for recent eight years. Korean J Gastroenterol 2006; 48:156-61
8. Na HS, Hong SJ, Yoon HJ, et al. Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication. Korean J Gastroenterol 2007; 50:170-5
9. Kim JJ, Reddy R, Lee M, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J AntimicrobChemother 2001; 47:459-61
10. Kim JM, Kim JS, Jung HC, et al. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother 2004; 48:4843-7
11. Hwang TJ, Kim N, Kim HB, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J ClinGastroenterol 2007; 44:536-43
12. Occhialini A, Urdaci M, Doucet-Populaire F, et al. Macrolide resistance in Helicobacter pylori: Rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997; 41:2724-8
13. Woo HY, Park DI, Park H, et al. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter 2009; 14:22-8
14. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102:1808-25
15. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-The Maastricht IV/Florence Consensus Report. Gut 2012; 61:646-64
16. Broutet N, Tchamgoué S, Pereira E, et al. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment PharmacolTher 2003; 17:99-109
17. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40:477-80
18. Taylor DE, Ge Z, Purych D, et al. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997; 41:2621-8.
19. Kim JG. Treatment of Helicobacter pylori infection. Korean J Gastroenterol 2005; 46:172-80
20. Gerrits MM, van Vliet AH, Kuipers EJ, et al. Helicobacter pylori and antimicrobial resistance: Molecular mechanisms and clinical implications. Lancet Infect Dis 2006; 6:699-709
21. Chun JY, Kim KJ, Hwang IT, et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res 2007; 35:e40
22. Lee HK, Chae HS, Kang JO, et al. Multicenter study for the frequency of 23S rRNA point mutations associated with clarithromycin resistance in Helicobacter pylori in Korea. Korean J ClinMicrobiol 2008; 11:84-9
23. Fischbach LA, van Zanten S, Dickason J. Meta-Analysis: The efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004; 20:1071-82
24. Kuepper-Nybelen J, Thefeld W, Rothenbacher D, et al. Patterns of alcohol consumption and Helicobacter pylori infection: Results of a population-based study from Germany among 6545 adults. Aliment PharmacolTher 2005; 21:57-64
25. Suzuki T, Matsuo K, Ito H, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006; 119:217-24